Essa Pharma Stock Probability of Future Stock Price Finishing Under 1.6
| EPIX Stock | USD 1.63 0.03 1.87% |
ESSA |
ESSA Pharma Target Price Odds to finish below 1.6
The tendency of ESSA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 1.60 or more in 90 days |
| 1.63 | 90 days | 1.60 | about 16.28 |
Based on a normal probability distribution, the odds of ESSA Pharma to drop to $ 1.60 or more in 90 days from now is about 16.28 (This ESSA Pharma probability density function shows the probability of ESSA Stock to fall within a particular range of prices over 90 days) . Probability of ESSA Pharma price to stay between $ 1.60 and its current price of $1.63 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days ESSA Pharma has a beta of -0.57 suggesting as returns on the benchmark increase, returns on holding ESSA Pharma are expected to decrease at a much lower rate. During a bear market, however, ESSA Pharma is likely to outperform the market. Additionally ESSA Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ESSA Pharma Price Density |
| Price |
Predictive Modules for ESSA Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ESSA Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ESSA Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ESSA Pharma is not an exception. The market had few large corrections towards the ESSA Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ESSA Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ESSA Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.16 | |
β | Beta against Dow Jones | -0.57 | |
σ | Overall volatility | 2.14 | |
Ir | Information ratio | -0.12 |
ESSA Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ESSA Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ESSA Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ESSA Pharma generated a negative expected return over the last 90 days | |
| ESSA Pharma has high historical volatility and very poor performance | |
| ESSA Pharma may become a speculative penny stock | |
| Net Loss for the year was (28.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ESSA Pharma currently holds about 174.6 M in cash with (22.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| ESSA Pharma has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Eikonizo Therapeutics Announces Investment by Novo Nordisk Advancing Lead Candidate EKZ-102 Toward Clinical Development |
ESSA Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ESSA Stock often depends not only on the future outlook of the current and potential ESSA Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ESSA Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.3 M | |
| Cash And Short Term Investments | 126.8 M |
ESSA Pharma Technical Analysis
ESSA Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. ESSA Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ESSA Pharma. In general, you should focus on analyzing ESSA Stock price patterns and their correlations with different microeconomic environments and drivers.
ESSA Pharma Predictive Forecast Models
ESSA Pharma's time-series forecasting models is one of many ESSA Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ESSA Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ESSA Pharma
Checking the ongoing alerts about ESSA Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ESSA Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ESSA Pharma generated a negative expected return over the last 90 days | |
| ESSA Pharma has high historical volatility and very poor performance | |
| ESSA Pharma may become a speculative penny stock | |
| Net Loss for the year was (28.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ESSA Pharma currently holds about 174.6 M in cash with (22.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| ESSA Pharma has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Eikonizo Therapeutics Announces Investment by Novo Nordisk Advancing Lead Candidate EKZ-102 Toward Clinical Development |
Additional Tools for ESSA Stock Analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.